Leerink Swann reiterated Outperform rating on Vivus (NASDAQ: VVUS), Arena Pharmaceuticals, Inc. (Nasdaq: ARNA), and Orexigen Therapeutics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE